Vitasora Health (ASX:VHL) Forward PE Ratio: 1.50 (As of Aug. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Vitasora Health Forward PE Ratio?

Vitasora Health ASX:VHL +8.33% Forward PE Ratio is 1.50 as of Aug. 15, 2026. The stock has 6 warning signs investors should review. Among 315 Healthcare Providers & Services companies, Vitasora Health ranks better than 99.37% on this metric.

Vitasora Health's Forward PE Ratio for today is 1.50.

Vitasora Health's PE Ratio without NRI for today is 0.00.

Vitasora Health's PE Ratio (TTM) for today is 0.00.


Vitasora Health  (ASX:VHL) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Vitasora Health Forward PE Ratio Related Terms


Vitasora Health Forward PE Ratio Historical Data

* Premium members only.

The historical data trend for Vitasora Health's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vitasora Health Forward PE Ratio Chart

Vitasora Health Annual Data
Trend 2024-06
Forward PE Ratio
0.87

Vitasora Health Semi-Annual Data
2024-06 2024-12
Forward PE Ratio 0.87 2.53

ASX:VHL vs VEEV, BTSG, HQY: Forward PE Ratio Comparison

For the Health Information Services subindustry, Vitasora Health's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vitasora Health Forward PE Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Vitasora Health's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Vitasora Health's Forward PE Ratio falls into.



Vitasora Health Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.

Frequently Asked Questions Learn more about Forward PE Ratio →
What does a Forward PE Ratio of 1.50 mean?
Vitasora Health (ASX:VHL) has a Forward PE Ratio of 1.50 as of Aug. 15, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Vitasora Health and its competitors. According to the industry distribution chart, Vitasora Health ranks #2 out of 315 companies in the Healthcare Providers & Services industry, placing it in the top 0.59999999999999%.
Is Vitasora Health's Forward PE Ratio too high?
Vitasora Health's current Forward PE Ratio is 1.50. The Healthcare Providers & Services industry median Forward PE Ratio is 19.02. Vitasora Health's value of 1.50 is 92.1% below this industry median. Based on the distribution chart, Vitasora Health ranks #2 out of 315 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers.
How does Vitasora Health's Forward PE Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Vitasora Health ranks #2 out of 315 companies for Forward PE Ratio. This places Vitasora Health in the top 1% of its industry — outperforming the majority of peers. The industry median Forward PE Ratio is 19.02. Vitasora Health's value of 1.50 is 92.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Healthcare Providers & Services company?
The median Forward PE Ratio among Healthcare Providers & Services companies is 19.02, based on 315 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vitasora Health's current Forward PE Ratio of 1.50 is 92.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Vitasora Health and its competitors. For the Healthcare Providers & Services industry, the median Forward PE Ratio is 19.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vitasora Health's current Forward PE Ratio is 1.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitasora Health stock overvalued right now?
Vitasora Health (ASX:VHL) has a current Forward PE Ratio of 1.50. The current Forward PE Ratio is 1.50 and 92.1% below the Healthcare Providers & Services industry median of 19.02. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Vitasora Health (ASX:VHL), the current Forward PE Ratio is 1.50 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vitasora Health Business Description

Other Exchanges VHLUF:USA
Address 432 Street Kilda Road, Level 9, Melbourne, VIC, AUS, 3004
Vitasora Health Ltd is engaged in healthcare technology and services, providing critical patient health tracking services to clinicians and healthcare teams. Through data-driven programs, clinical technology, and support tools, it enables healthcare professionals to extend the capacity of care beyond the clinic. The company operates in Australia and the USA, with the majority of its revenue coming from the USA. The United States reportable segment, through the acquisition of Access Telehealth and Orb Health, provides reportable segment activities such as a broader value proposition and solutions for managing the majority chronic disease states, including Cardiovascular, Diabetes, Chronic Obstructive Pulmonary Disease (COPD), and Obesity.